Dr. Gabrielle Mavelian, DO
What this data tells you about Dr. Mavelian
Dr. Gabrielle Mavelian is a student in an organized health care education/training program specialist in Fort Worth, TX, with 9 years of NPI registration. Based on federal Medicare data, Dr. Mavelian performed 3,434 Medicare services across 2,649 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mavelian received a total of $36 from 2 pharmaceutical and/or device companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mavelian is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 471 | $79 | $219 |
| Blood draw (venipuncture) | 414 | $8 | $10 |
| Comprehensive metabolic blood panel | 362 | $10 | $29 |
| Complete blood count (CBC) with differential | 246 | $8 | $22 |
| Thyroid stimulating hormone (TSH) test | 238 | $16 | $48 |
| Lipid panel (cholesterol and triglycerides) | 237 | $13 | $37 |
| Urinalysis with microscopic exam | 196 | $3 | $9 |
| Hemoglobin A1c test (diabetes monitoring) | 195 | $9 | $27 |
| Vitamin D level test | 189 | $29 | $75 |
| Annual wellness visit, follow-up | 181 | $127 | $240 |
| Vitamin B-12 level test | 94 | $15 | $42 |
| Urine microalbumin (protein) analysis | 50 | $6 | $13 |
| Creatinine test (kidney function) | 50 | $5 | $15 |
| Free thyroxine (T4) test | 40 | $9 | $25 |
| Pneumonia vaccine administration | 40 | $30 | $59 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 38 | $280 | $568 |
| Office visit, established patient, complex (40-54 min) | 35 | $130 | $295 |
| Urine culture, bacterial colony count | 33 | $8 | $24 |
| Automated urinalysis | 29 | $2 | $7 |
| Parathyroid hormone level test | 24 | $40 | $114 |
| Phosphate level test | 19 | $5 | $13 |
| Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies | 19 | $24 | $68 |
| Ferritin level test (iron stores) | 18 | $13 | $38 |
| Iron level test | 18 | $6 | $18 |
| Iron binding capacity test | 18 | $9 | $24 |
| Bacterial culture, aerobic | 18 | $8 | $24 |
| Antibiotic sensitivity test | 18 | $8 | $24 |
| Flu vaccine, quadrivalent | 17 | $75 | $145 |
| Flu vaccine administration | 17 | $30 | $51 |
| Hepatitis c antibody measurement | 16 | $14 | $40 |
| Prostate cancer screening; prostate specific antigen test (psa) | 16 | $19 | $51 |
| C-reactive protein test (inflammation marker) | 15 | $5 | $15 |
| New patient office visit (45-59 min) | 15 | $99 | $334 |
| PSA test (prostate cancer screening) | 12 | $18 | $51 |
| Sed rate test (inflammation marker) | 12 | $3 | $8 |
| Office visit, established patient (20-29 min) | 12 | $63 | $150 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 12 | $163 | $340 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mavelian is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mavelian experienced with office visit, established patient (30-39 min)?
Does Dr. Mavelian receive payments from pharmaceutical companies?
How do Dr. Mavelian's costs compare to other student in an organized health care education/training programs in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology